How do you choose between resmetirom and semaglutide in the treatment of MASH?  

I write a disclaimer to start, because use of resmetirom ($5000 per month) and semaglutide ($1600 per month) at this time cannot be used across the board with any patient with hepatic steatosis. It's important to highlight how we define steatohepatitis (MASH/NASH) in order to best figure out how to ...